Nitta Gelatin India Ltd., a joint venture between Nitta Gelatin, Japan, and the Kerala State Industrial Development Corporation (KSIDC), announced a ₹200 crore expansion plan to fuel its next phase of growth.
The investment will fund the establishment of a new collagen peptide plant, a state-of-the-art gelatin manufacturing unit, and a new corporate headquarters in Kakkanad, Kerala. The expansion places NGIL in a strong position to meet rising global demand for collagen-based functional ingredients. Manufacturers widely use these ingredients in wellness, joint health, and metabolic care.
Scaling to Meet Demand in Functional Ingredients
“Our upgraded facility will allow us to respond to this demand with scale and speed,” said Praveen Venkataramanan, Managing Director of NGIL. The move marks a strategic shift for the company. It builds on NGIL’s five-decade evolution—from ossein manufacturing to pharma-grade gelatin. Now, the company is positioning itself as a leader in clean-label, health-focused bio-ingredients.
Revenue to Surge Post-Expansion
Currently generating ₹500 crore in annual revenue, NGIL projects a significant boost following the expansion. The company expects its turnover to reach ₹750–800 crore within two years. This growth will be driven by added production capacity and entry into high-growth segments like collagen peptides. With this investment, NGIL aims to reinforce its leadership in sustainable and science-backed ingredients. These products are globally relevant and align with modern health and nutrition trends.
